Find your perfect fit.

Great companies are being built by amazing teams. Come be a part of it.
At Menlo Ventures, we invest in companies that will change how we live and work. To do that, they need creative thinkers, problem solvers, builders, and business leaders. They look to Menlo for help building their teams.
Tell us more about your professional DNA to get discovered by the companies we back.

Director, Clinical Quality Assurance

Pliant Therapeutics

Pliant Therapeutics

Quality Assurance
South San Francisco, CA, USA
Posted on Tuesday, May 21, 2024

Pliant Therapeutics is a late-stage biopharmaceutical company focused on the discovery and development of novel therapies for fibrotic diseases. Founded by Third Rock Ventures with world-renowned academic thought leaders, Pliant is raising the bar to meet the unmet medical needs of physicians, patients and families impacted by fibrotic diseases. As the leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, Pliant is developing small molecule drug candidates specifically designed to impact the fibrotic process.

The Company’s lead product candidate, bexotegrast (PLN-74809), is an oral small molecule, selective inhibitor of the αvβ1 and αvβ6 integrins that play a key role in multiple fibrotic pathways. Bexotegrast has received Fast Track Designation and Orphan Drug Designation from the U.S. Food and Drug Administration for both idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC) and Orphan Drug Designation from the European Medicines Agency in IPF and PSC. Pliant is currently conducting BEACON-IPF, a Phase 2b/3 trial of bexotegrast for the treatment of IPF and INTEGRIS-PSC, a Phase 2a trial of bexotegrast for the treatment of PSC.

Pliant is conducting a Phase 1 study for its third clinical program, PLN-101095, a small molecule, dual-selective inhibitor of αvß8 and αvß1 integrins, that is being developed for the treatment of solid tumors. The Company also has discovery and development programs in oncology and muscular dystrophies.


The Director of Clinical Quality Assurance (CQA) is a hands-on position responsible to ensure Pliant Therapeutics sponsored clinical trials adhered to applicable GCP regulations (e.g., FDA, ex-US, country-specific), ICH guidelines, Pliant Standard Operating Procedures (SOPs), and current industry standards and practices. The candidate will support clinical compliance and inspection readiness. This position will be reporting to Senior Director, CQA.

The Director of CQA must thrive in a fast-paced, innovative environment while remaining flexible, proactive, resourceful, effective, and efficient. Excellent interpersonal skills, ability to develop important relationships with key stakeholders, good negotiation skills, ability to analyze issues to support relevant and realistic plans, and support program recommendations. Demonstrated ability to support strategic and tactical decisions into action; excellent analytical skills, and to support plans to resolve issues and mitigate risks.

This is a hybrid position.


  • Represent clinical quality at the program team meetings and provide operational quality guidance to the development teams.
  • Represent clinical quality at CROs operational meetings, service provider meetings, and service/vendor quality meetings.
  • Provide quality oversight of the ongoing clinical programs, ensuring that the appropriate assessment and monitoring, risk assessment and risk mitigations are in place.
  • Review clinical trial documentation for data integrity and compliance with Good Clinical Practice and regulations including key clinical and IND/NDA enabling documents.
  • Provide clinical quality support for Health Authority Inspections, service providers and CROs operational meetings, as well as inspection readiness activities.
  • Collaborate with Clinical Development (including PV/Safety), Regulatory Affairs, and Development Operations (including Clinical Operations, Data Management, and Biostatistics), CROs and clinical sites to support overall GCP compliance and inspection readiness.
  • Support managing a risk-based clinical Quality Management System (QMS) for GCP QA in compliance with applicable regulatory requirements (US and OUS), and company policies.
  • Provide compliance advice and guidance to achieve continuous quality improvement and effective quality assurance and continue to foster Plaints’ culture of continuous improvement with emphasis on efficiency and effectiveness.
  • Support the implementation of internal standards, policies, and procedures to ensure compliance, which includes Co-author and review Standard Operating Procedures.
  • Develop and implement study specific audit plans and annual audit schedules and develop periodic compliance/metric reports.
  • Support the selection of clinical service providers and qualification activities
  • Support quality event management for assigned clinical programs and/or studies, including assessment of potential root causes and CAPA. Assist with the oversight of the completion of corrective and preventative actions (CAPA) upon audit completion.
  • Responsible for GCP training to include development and revision of training matrices and training new GCP personnel.
  • Conduct or provide support of GCP, GCLP, GLP, and GVP audits of clinical investigator sites, Contract Research Organizations (CROs), contract clinical laboratories, and processes/systems to determine compliance status. This will include support of contract GXP auditors performing various GXP audit types.


To perform this job successfully, an individual must be able to perform each essential duty. The requirements listed below are representative of the knowledge, skill, abilities and prior experience required.

  • Bachelor’s degree required with 10+ years’ experience with at least 5 years' experience in Clinical Quality Assurance or Clinical Operations. Advanced degree in a scientific field preferred. Quality assurance professional certification is a plus.
  • Broad knowledge of risk-based quality systems approaches consistent with ICH E6 (R2) for Good Clinical Practice. Experience with all phases of clinical trials.
  • Knowledge and practical application of ICH E8 (R1)
  • Ability to interpret and apply GCP, EU, FDA, and ICH regulations and guidelines including understanding and application of domestic and international regulatory requirements.
  • Previous experience of Good Clinical Practice (GCP), and Good Clinical Laboratory Practice (GCLP).
  • Knowledge and experience implementing phase appropriate procedures and processes and familiarity with data integrity controls.
  • Experience interacting with domestic and international clinical service providers for early phase to late-stage clinical trials.
  • Proven track record of industry success including experience in regulatory inspection preparation and supporting inspections.
  • Experience with the audit process, auditing clinical sites, and auditing clinical service providers is preferred.
  • Clinical Quality Auditor certificate is a plus.
  • Some travel may be required.

Pliant requires all new hires to be fully vaccinated prior to the first date of employment (subject to any legally required exemptions).

The annual base salary for this role is $210,000 - $230,000. Individual pay may vary based on additional factors, including, and without limitation job-related skills, experience, work location and relevant education or training. Pliant’s compensation package also includes benefits, equity, and annual target bonus for fulltime positions.

To understand how Pliant complies with and manages your personal information with respect to the California Consumer Privacy Act, please visit